C9orf72 and frontotemporal dementia: Next, to test whether the decreased levels of PML nuclear immunoreactivity observed was associated with expanded G4C2 repeats in C9orf72-ALS-FTD, we used double immunofluorescence labeling with established polyGA and PML antibodies.